RU
Address
220006, Minsk, Leningradskaya Str. 6, office 2
Tel.: +375 17 363-88-92
E-mail: medjournal@bsmu.by

Интенсивная терапия сепсиса

О. Т. Прасмыцкий, С. С. Грачев БГМУ
2015 №4 | Лекции
Аннотация
Список литературы
Скачать полнотекстовую статью
В данном литературном обзоре представлен анализ и стратегия ведения пациентов с сепсисом различной этиологии. Приводятся критерии диагноза сепсис, тяжелый сепсис, септический шок в соответствии с общепризнанными рекомендациями.
Ключевые слова:
сепсис, интенсивная терапия, критерии выживания, вазопрессоры, коллоидные растворы
Sepsis intensive therapy

This literature review presents the analysis and strategy of the management of patients with sepsis of various etiologies. Criteria diagnosis of sepsis, severe sepsis, septic shock, in accordance with generally accepted guidelines.

Keywords
sepsis, intensive care, survival criteria, vasopressors, colloidal solutions
  • 1. Еременко, Ю. Г., Дорохин К. М., Шапель И. А., Парфенов А. Н., Мельниченко Е. Н. // Диагностика и лечение сепсиса. «Здравоохранение». – 2000. – № 12. – С. 45–48.
  • 2. Еременко, Ю. Г., Шапель И. А., Виноградов С. В., Якубцевич Р. Э. // Пути снижения летальности при сепсисе. «Медицинская панорама». – 2001. – С. 7–10.
  • 3. Завада, Н. В. Хирургический сепсис / Н. В. Завада, Ю. М. Гаин, С. А. Алексеев. – Минск: ООО «Новое знание», 2003. – 8 с.
  • 4. Макарова, Н. П. Синдром эндогенной интоксикации при сепсисе / Н. П. Макарова, И. Н. Коничева // Анестезиология и реаниматология. – М.: Медицина, 1995. – № 6. – С. 4–8.
  • 5. Прасмыцкий, О. Т., Грачев С. С. К вопросу о переливании коллоидных растворов при инфузионной терапии / «Медицинский журнал». – 2015. – № 1. – С. 39–46.
  • 6. Савельев, В. С. Абдоминальная хирургия: клиника, диагностика, антимикробная терапия / В. С. Савельев, Б. Р. Гельфанд. – М.: Литера, 2006. – С. 3–7.
  • 7. Савельев, В. С. Сепсис в начале XXI века. Классификация, клинико-диагностические концепции и лечение. Патологоанатомическая диагностика / В. С. Савельев, Б. Р. Гельфанд. – М.: Литера, 2006. – 20 с.
  • 8. Angus, D. C., Wax, R. S. Epidemiology of sepsis: an update / Critical Care Medicineю. – 2001. – Vol. 29. – P. S109–S116.
  • 9. Bayer, O., Reinhart K., Kohl M. et al. Effects of fluid resuscitation with synthetic colloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis / Critical Care Medicine. – 2012. – Vol. 40. – P. 2543–2551.
  • 10. Bone, R., Balk R., Cerra F. et al. // Amercan College of Chest Physicians/Society of Crtical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and quidelines for the use of innovative therapies in sepsis. Chest 1992; 101 (6); 1644–1655.
  • 11. Bone, R., Balk R., Cerra F. et al.// Amercan College of Chest Physicians/Society of Crtical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and quidelines for the use of innovative therapies in sepsis. Critical Care Medicine. – 1992. – № 20 (6). – P. 864–874.
  • 12. Cohen, J., Abraham E. Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock. / The Journal of Infectious Diseases. – 1999. – Vol. 180. – Р. 116–121.
  • 13. De Backer, D., Aldecoa C., Njimi H., Vincent J.-L. Dopamine versus norepinephrine in the treatment of septic shock: A metaanalysis / Critical Care Medicine. – 2012. – Vol. 40. – P. 725–730.
  • 14. Dellinger, R. Phillip, Levy Mitchell M., Rhodes Andrew B. S. et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 / Critical Care Medicine. – 2013. – Vol. 41. – P. 580–637.
  • 15. Fredriksson, K., Rooyackers O. Mitochondrial function in sepsis: respiratory versus leg muscle / Critical Care Medicine. – 2007. – Vol. 35. – S449–S453.
  • 16. Gaieski, D. F., Edwards J. M., Kallan M. J., Carr B. G. Benchmarking the incidence and mortality of severe sepsis in the United States. / Critical Care Medicine. – 2013. – Vol. 41. – P. 167–1174.
  • 17. Gattas, DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systemic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med. 2013.
  • 18. Glass, Todd F., Knapp Jason B. S., Amburn Philip et al. Use of artificial intelligence to identify cardiovascular compromise in a model of hemorrhagic shock / Critical Care Medicine. – 2004. – Vol. 32. – P. 450–456.
  • 19. Haase, N., Perner A., Hennings L. I. et al. Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. – BMJ. – 2013. – P. 1839
  • 20. Ibsen, M., Perner A. Perioperative treatment of patients with sepsis. / Current opinion in anaesthesiology. – 2013. –Vol. 26:3. Р. 348–353.
  • 21. Kopterides, P., Siempos I. I., Tsangaris I., Tsantes A.,Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systemic review and meta-analysis of randomized controlled trials / Critical Care Medicine. – 2010. – Vol. 38. – P. 2229–2241.
  • 22. Lauzier, F., Cook D., Griffith L., Upton J., Crowther M. Fresh frozen plasma transfusion in critically ill patients / Critical Care Medicine. – 2007. – Vol. 35. – P. 1655–1659.
  • 23. Levy, M. M., Dellinger R. P., Townsend S. R. et al.The Surviving Sepsis Campaign: results of an international guidelinebased performance improvement program targeting severe sepsis / Critical Care Medicine. – 2010. – Vol. 38. – P. 367–374.
  • 24. McClave, S. A., Martindale, R. G., Vanek, V. W. et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A. S. P. E. N.) / J Parent Ent Nutr. – 2009. – Vol. 33. –P. 277–316.
  • 25. Messmer, K. F. W Blood rheology factors and capillary blood flow. In: Guttierrez G., Vincent J. L, eds. Tissue oxygen utilization. – Berlin: Springer-Verlag, 1991. – P. 103–113.
  • 26. Myburgh, J. A., Finfer S., Bellomo R., Billot L. et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care / The New England Journal of Medicine. – 2012. – Vol. 367. – P. 1901–1911.
  • 27. Napolitano L. M. et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care / Critical Care Medicine. – 2009. – Vol. 37. – P. 3152–3157.
  • 28. Okamura Y., Yokoi H. Development of a point-of-careassay system for measurement of presepsin (sCD14-ST). Clin Chim Acta. – 2011. – 412 (23–24). – P. 2157–61.
  • 29. Opal, S. M, Cohen, J. Clinical Gram-positive sepsis: does it fundamentally differ from Gram-negative bacterial sepsis? / Critical Care Medicine. – 1999. – Vol. 27. – P. 1608–1616.
  • 30. Ranzani, O. T., Ferrer M., Esperatti M., Giunta V. et al. Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia / Critical Care Medicine. – 2012. – Vol. 40. – P. 2552–2561.
  • 31. Rivers, E., Nguyen B., Havstad S. et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock /The New England Journal of Medicine. – 2001. – Vol. 345. –P. 1368–1377.
  • 32. Rubulotta, F., Marshall J. C., Ramsay G., Nelson D., Levy M., Williams M. Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis / Critical Care Medicine. – 2009. – Vol. 37. – P. 1329–1335.
  • 33. Slama T. G. Gram-negative antibiotic resistance: there is a price to pay / Critical Care. – 2008. – Vol. 12 (Suppl 4). – S4.
  • 34. Vincent J. L. et al. Sepsis in European intensive care units: Results of the SOAP study / Critical Care Medicine. – 2006. – Vol. 34. – P. 344–353.